GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 31.05
+2.80 (9.91%)
Jul 30, 2026, 1:14 PM CST
GeneFerm Biotechnology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 663.87 | 677.1 | 521.16 | 793.77 | 633.96 | 522.33 |
Revenue Growth | 16.63% | 29.92% | -34.34% | 25.21% | 21.37% | 41.82% |
Gross Profit Gross Profit Growth | 176.67 | 190.8 | 96.75 | 286.35 | 222.16 | 192.65 |
Operating Income Operating Income Growth | 31.47 | 46.08 | -34.41 | 153.57 | 101.99 | 78.84 |
Net Income Net Income Growth | 15.7 | 28.86 | -22.53 | 124.62 | 93.45 | 57.41 |
Earnings Per Share EPS Growth | 0.38 | 0.70 | -0.54 | 2.99 | 2.20 | 1.32 |
EPS Growth | - | - | - | 35.63% | 66.87% | 725.71% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biotechnology Biotechnology Growth | 664.1 | 681.13 | 523.08 | 796.93 | 635.65 | 528.89 |
Revenue from Internal Divisions Revenue from Internal Divisions Growth | - | -4.03 | -1.92 | -3.16 | -1.68 | -6.55 |
Total Total Growth | 663.87 | 677.1 | 521.16 | 793.77 | 633.96 | 522.33 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 278.95 | 280.26 | 122.45 | 120.15 | 100.69 | 539.61 |
Total Debt Total Debt Growth | 321.81 | 324.23 | 234.92 | 127.44 | 181.02 | 437.22 |
Net Cash (Debt) Net Cash Growth | -42.86 | -43.97 | -112.47 | -7.29 | -80.33 | 102.39 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.03 | -1.06 | -2.71 | -0.18 | -1.89 | 2.21 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 86.31 | 99.31 | 8.09 | 190.31 | 122.43 | 112.23 |
Capital Expenditures CapEx Growth | -25.22 | -23.42 | -22.4 | -69.94 | -278.18 | -144.88 |
Free Cash Flow Free Cash Flow Growth | 61.09 | 75.89 | -14.31 | 120.37 | -155.74 | -32.65 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 26.61% | 28.18% | 18.56% | 36.08% | 35.04% | 36.88% |
Operating Margin | 4.74% | 6.80% | -6.60% | 19.35% | 16.09% | 15.09% |
Pretax Margin | 3.06% | 5.12% | -5.27% | 19.33% | 17.38% | 13.48% |
Profit Margin | 2.37% | 4.26% | -4.32% | 15.70% | 14.74% | 10.99% |
FCF Margin | 9.20% | 11.21% | -2.74% | 15.17% | -24.57% | -6.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.700 | 0.700 | - | 2.000 | 1.500 | 1.000 |
Dividend Per Share Growth | 0% | - | - | 33.33% | 50.00% | 1103.93% |
Dividend Yield | 2.31% | 1.48% | - | 2.83% | 2.40% | 2.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 74.60 | 69.31 | - | 24.79 | 29.68 | 31.51 |
P/FCF Ratio | 19.17 | 26.36 | - | 25.66 | - | - |
PS Ratio | 1.76 | 2.95 | 3.74 | 3.89 | 4.38 | 3.46 |